08 April 2022
Check out what the MTPConnect team got up to in March!
08 April 2022
MTPConnect co-exhibitor on the Australian Pavilion at world’s largest biotechnology convention BIO 2022
As part of its commitment to opening international markets and boosting access to international supply chains, MTPConnect has joined the AusBiotech-led Australian Pavilion as co-exhibitor at the BIO International Convention 2022 in San Diego, California.
06 April 2022
MTPConnect to fund DMTC project for Artificial Intelligence-assisted deep dive into health biosecurity capability
MTPConnect has announced it is funding a new project with DMTC Limited to provide a picture of the capability and capacity of Australia’s health biosecurity ecosystem. This will include end-to-end supply chains and workforce. Leveraging funding for MTPConnect from the Australian Government, the project will use Artificial Intelligence (AI) and machine learning to create a comprehensive digital database of sovereign capability and capacity in the health biosecurity sector.
06 April 2022
MTPConnect and Pathology Technology Australia to Develop Action Plan to Build Sovereign Manufacturing Capability in Diagnostic Tests
MTPConnect has secured funding from the Australian Government to develop a national Action Plan for building end-to-end sovereign manufacturing capability for diagnostic tests. The Action Plan will be developed in close partnership with Pathology Technology Australia (PTA) - the peak body representing manufacturers and suppliers of tests and technology used in pathology laboratories, hospitals, general practice and for self-testing.
05 April 2022
Read our latest case study on the Medihood - a groundbreaking patient isolation hood developed by a multidisciplinary team of world-leading experts led by the University of Melbourne that protects healthcare workers and nearby patients from COVID-19 and other infectious respiratory diseases. Supported by our BTB program with MRFF funding.
04 April 2022
Canthera Discovery's predecessor, Cancer Therapeutics CRC, wins the Cooperative Research Australia (CRA) Excellence in Innovation Award for Research Commercialisation at an award ceremony at Parliament House in Canberra last week.
04 April 2022
Introducing Stephanie Morris - Director of Innovation and Translation - Adelaide Intermediary Program
We are excited to welcome Stephanie Morris to MTPConnect as the Director of Innovation and Translation for our Adelaide Intermediary Program, based in Adelaide.
31 March 2022
Now in its 6th year, this cross-organisational Mentoring program aims to support mid-career women working in health and medical research ecosystem on their journey to leadership roles. In 2022, the unique program will be delivered in both Sydney and Canberra starting in May. Applications are open until 15 April 2022.
24 March 2022
Senior representatives of BioNTech, the company behind Pfizer’s COVID-19 vaccine, have been in Australia this week.
23 March 2022
We are delighted to welcome Natalie Vella to our communications team in the role of Social Media Specialist, based in Melbourne.
18 March 2022
A multi-million-dollar investment agreement by Aspen Medical in Queensland-based health-tech company WearOptimo, has cemented a strategic partnership between the two companies to revolutionise precision medicine globally.
11 March 2022
Check out what MTPConnect got up to in February!
10 March 2022
Today we are delighted to announce that Deborah Sippitts is joining MTPConnect as Senior Manager Communications working with Caroline Duell and Libby Pearce, based in Melbourne.
01 March 2022
In our latest case study, we explain how biotech company Cincera, bolstered by MTPConnect's BTB program, is developing a drug to treat severe and life-threatening liver diseases.
28 February 2022
We are pleased to announce that our partnership with Life Sciences WA (LSWA) has been awarded an X-TEND WA program grant, supported by the Department of Jobs, Tourism, Science and Innovation and part of the New Industries Fund.